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ABSTRACT
Objectives To examine the familial risk of systemic 
lupus erythematosus (SLE) and rheumatoid arthritis (RA), 
including juvenile rheumatoid/idiopathic arthritis (JRA), 
in a population-based setting; and to determine whether 
patterns of transmission differ according to the sex of 
the parent or offspring, in order to provide insight into 
the potential impact of X-chromosomal factors on sex 
disparities in these autoimmune diseases.
Methods A population-based cohort of parent–offspring 
triads from Denmark (1977–2010) was established. SLE 
and RA incidence rates among offspring were calculated, 
and Cox regression was performed to assess the sex-
specifi c risk of disease in offspring according to maternal 
or paternal disease history.
Results Among 3 513 817 parent–offspring triads, there 
were 1258 SLE cases among offspring (1095 female, 163 
male) and 9118 cases of RA/JRA (6086 female, 3032 male). 
Among female offspring, SLE risk was nearly the same 
according to maternal (HR 14.1) or paternal (HR 14.5) history 
(p=NS); likewise among male offspring, risk according to 
maternal (HR 5.5) and paternal (no cases) history were similar 
(p=NS). For RA, all risk estimates were similar, regardless of 
the sex of the offspring or parent (HR 2.6–2.9; p=NS).
Conclusions The authors quantifi ed the familial risk 
of SLE and RA in a nationwide cohort study. For both 
diseases, transmission was comparable among both 
female and male offspring of maternal and paternal cases. 
These data provide evidence at the population level that 
X-chromosomal factors do not play a major role in sex 
disparities associated with the risk of SLE and RA.
Like the majority of autoimmune diseases, systemic 
lupus erythematosus (SLE) and rheumatoid arthritis 
(RA) disproportionately affect women, with female 
to male ratios of up to 9:1.1 Although sex steroid 
hormones probably contribute to the increased inci-
dence observed among women, this explanation is 
simplistic.2 Genomic differences between men and 
women may play a role in autoimmune and other 
immunological diseases, and X-chromosomal factors, 
including X-linked susceptibility genes or incomplete 
X inactivation, have been hypothesised to contribute 
to the female preponderance of these diseases.3 4 It is 
estimated that the X chromosome contains close to 
6% of genomic DNA in humans, or approximately 
1100 known genes.5 Recent studies have suggested 
potential alleles on the X chromosome that may be 
relevant to RA and SLE,6 7 and investigation of candi-
date genes on the X chromosome that may be asso-
ciated with autoimmune disorders is ongoing.
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Familial aggregation has been identifi ed for many 
autoimmune diseases, including SLE and RA.8–14 
For instance, based on data from case–control 
studies, it has been estimated that offspring of a 
parent with SLE have more than three times the 
risk of developing SLE compared with controls 
with no family history (OR 3.3, 95% CI 1.2 to 
8.6);15 a similar degree of risk for developing RA 
among offspring with an affected parent has 
been reported (OR 3.5, 95% CI 1.1 to 10.8).16 
However, familial data for SLE and RA have often 
been derived from multiplex families recruited for 
genetics studies, which by defi nition include fami-
lies with more than one case of disease. Also, it is 
unclear whether risk differs for maternal versus 
paternal transmission, or according to the sex of 
the offspring. Men have single X chromosomes, 
with all cells having maternally derived alleles on 
the X chromosome. While women inherit both 
maternal and paternal X chromosomes, only a sin-
gle ‘active’ X chromosome is normally expressed in 
each cell (transcription of the inactive X is silenced). 
Epigenetic mechanisms (gene modifi cations other 
than alterations in the DNA sequence), such as 
DNA methylation, are responsible for inactivation 
of the second X chromosome. The process of X 
chromosome inactivation is purportedly random, 
and therefore is expected to yield approximately 
equivalent proportions of cells in women who 
express maternal or paternal X alleles. If there are 
important risk allele(s) on the X chromosome, 
male offspring of mothers with SLE or RA would 
be expected to have a higher risk of disease than 
male offspring of affected fathers, because sons 
do not inherit a paternal X chromosome. Female 
offspring, however, would be expected to experi-
ence an equivalent magnitude of familial associa-
tion regardless of whether the parental proband 
was maternal or paternal. If such patterns were 
refuted utilising population-based data, it would 
suggest that X-linked chromosomes do not play 
a substantial role in disease risk. Identifi cation 
of differential risks would provide aetiological 
clues.
Laboratory research related to the intersection 
of sex, genetics and epigenetics in autoimmune 
diseases is ongoing, with a lack of complementary 
epidemiological data. We conducted this popula-
tion-based study, utilising Danish registry data, to 
further understanding of the familial risk of disease 
and sex disparities in the risk of two major systemic 
autoimmune diseases⎯RA and SLE.
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METHODS
Study population
This population-based cohort study used linked Danish health 
registries for the period 1 January 1977 to 1 January 2010. The 
Danish Civil Registration System was utilised to produce indi-
vidual-level data linkages, and also to establish parent–offspring 
linkages, which are available from 1950 onward. The Danish 
National Registry of Patients provided diagnostic data, based 
on the International Classifi cation of Diseases (ICD) coding 
structure (ICD-8 until 1993; ICD-10 from 1994 onward). This 
database records hospitalisations since 1977 and outpatient vis-
its since 1995. Further details regarding Danish registry data are 
described elsewhere.17–19 This research was approved by the 
Danish ethical review boards and the Danish Data Protection 
Agency.
Cases of SLE and RA, including juvenile rheumatoid/idio-
pathic arthritis (JRA), were identifi ed based on relevant ICD-8 
and ICD-10 diagnostic codes (see supplementary appendix, 
available online only). The date of the fi rst ICD code for a given 
disease in the patient record was considered the diagnosis date.
Statistical methods
The analysis included all offspring–parent triads followed up 
during the study period. SLE and RA history, including diagnosis 
dates, were determined for all offspring and parents. Analyses 
were carried out separately for female and male offspring, in 
order to investigate sex-specifi c effects. Crude incidence rates of 
disease among the offspring, according to maternal and pater-
nal history of disease, were calculated by dividing the number 
of cases by person-time at risk, expressed per 100 000 person-
years. In order to take into account person-time at risk, Cox 
proportional hazards regression was performed, using a left-
truncated approach and with offspring age as the timescale.20 
21 Both maternal and paternal disease histories were included as 
covariates in the primary models. Sensitivity analyses were con-
ducted to account for calendar period, by adjusting for the year 
of birth, in 5-year groups, in the modelling. Further sensitivity 
analyses were conducted in which families with more than one 
affected offspring were excluded, so that these families were not 
over-weighted in the analyses. The Wald χ2 statistic was used 
to compare hazard ratios (HR) between maternal and paternal 
history. Data management and analysis was performed using 
SAS v9.2 software.
RESULTS
The study population included 3 513 817 eligible parent–
offspring triads. Of these, 1015 female offspring and 1344 male 
offspring had less than 1 day at risk (due to neonatal death) and 
were thus excluded from analyses incorporating person-time. 
There was a total of 1258 cases of SLE among offspring (1095 
female, 163 male) and 9118 cases of RA/JRA among offspring 
(6086 female, 3032 male). Table 1 presents incidence rates and 
HR with 95% CI corresponding to maternal and paternal history 
of disease, stratifi ed by the sex of the offspring.
A parental history of SLE was strongly associated with the 
risk of SLE in offspring (HR >14.0 among female offspring for 
either maternal or paternal history; HR 5.5 among male off-
spring for maternal history; HR zero for paternal history due to 
absence of cases). A parental history of RA was also associated 
with increased risk of RA among offspring at statistically signifi -
cant levels, compared with offspring without a parental history 
of RA. However, magnitudes of association were weaker than 
those observed for SLE (HR ranging from 2.4 to 2.9 in female 
and male offspring). When JRA cases were included in the total 
for RA, HR were similar to those for RA cases alone (HR ranging 
from 2.4 to 2.7).
As presented in table 1, when HR for maternal versus pater-
nal history of disease were compared according to the sex of 
Table 1 Sex-specifi c incidence rates and HR for SLE and RA, including JRA according to the maternal or paternal history of disease, Denmark, 
1977–2010
Parental history of 
disease 











person-years HR (95% CI)* p Value†
Maternal SLE
 No 1078 40 656 405 2.7 Referent 0.9588 162 44 269 324 0.4 Referent 0.9753
 Yes 17 44 889 36.3 14.1 (8.7 to 22.8) 1 48 468 2.0 5.5 (0.8 to 39.3)
Paternal SLE
 No 1090 40 690 357 2.7 Referent 163 44 306 784 0.4 Referent
 Yes 5 10 937 45.3 14.5 (6.0 to 34.9) 0 11 008 – 0 (0)‡
Maternal RA
 No 4301 40 202 250 10.7 Referent 0.7233 1882 43 767 476 4.3 Referent 0.4651
 Yes 203 483 783 42.0 2.7 (2.4 to 3.1) 86 541 077 15.9 2.6 (2.1 to 3.2)
Paternal RA
 No 4394 40 439 961 10.9 Referent 1916 44 026 469 4.4 Referent
 Yes 110 246 073 44.7 2.8 (2.4 to 3.4) 52 282 083 18.4 2.9 (2.2 to 3.8)
Maternal RA/JRA
 No 5850 40 190 344 14.6 Referent 0.9823 2931 43 757 816 6.7 Referent 0.5844
 Yes 236 485,075 48.7 2.7 (2.4 to 3.1) 101 542 648 18.6 2.4 (2.0 to 2.9)
Paternal RA/JRA
 No 5964 40 427 902 14.8 Referent 2974 44 017 063 6.8 Referent
 Yes 122 247 517 49.3 2.7 (2.2 to 3.2)  58 283 400 20.5 2.6 (2.0 to 3.4)  
*Adjusted for maternal/paternal history.
†p Value comparing maternal versus paternal history risk estimates.
‡Upper bound not calculated due to no cases among male offspring.
JRA, juvenile rheumatoid/idiopathic arthritis; SLE, systemic lupus erythematosus; RA, rheumatoid arthritis.
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the offspring, magnitudes of risk were similar regarding either 
parent, both for SLE and RA (all p values NS). Results did not 
differ appreciably after adjustment for calendar period (in 5-year 
groups; table 2).
There were 12 families with SLE in more than one offspring 
(all with SLE in two offspring). For RA, 132 families had the 
disease in more than one offspring (128 families with two off-
spring and four families with more than two offspring affected). 
Results from sensitivity analyses excluding families with more 
than one affected offspring yielded numbers similar to those 
from the main models (table 2).
DISCUSSION
While familial aggregation of SLE and RA has long been recog-
nised, our study is unique in its population-based design and 
focus on intergenerational patterns between parents and their 
offspring, rather than within more broadly defi ned fi rst or sec-
ond degree kinships. In addition, we accounted for the age of 
the offspring and person-time at risk. We also analysed incident 
cases, instead of simply reporting proportions of prevalent cases 
among offspring of affected relatives.
Our data extend former research. We thus showed in the 
Danish population, that a parental history of SLE is associated 
with up to a 14-fold increased risk of SLE among offspring, com-
pared with a negative parental history of SLE. The magnitude 
of this risk is substantially higher than previous reports,15 sug-
gesting that earlier studies may have underestimated familial 
risk. In contrast, our estimates for RA (HR ranging from 2.6 to 
2.9) correspond more closely to previous data.22 SLE and RA are 
both complex diseases with multifactorial aetiologies involving 
the interplay of genetic and environmental factors. Our data 
imply that the genetic basis of SLE may be stronger than that for 
RA. Other lines of epidemiological evidence, such as temporal 
trends, also lend credence to this theory. For instance, while data 
indicate that the incidence of SLE has been relatively stable over 
calendar time,23 the incidence of RA in recent decades has been 
estimated to be decreasing,24 25 indicating a modulation of RA 
risk by environmental factors.
When we examined whether a parental history of disease had 
a differential impact according to the sex of the parent or off-
spring, we confi rmed that female offspring are at greater risk 
of disease than male offspring. This is consistent with well-
recognised higher incidence rates among female offspring. As 
hypothesised, for both SLE and RA, similar magnitudes of risk 
were observed among female offspring in association with a 
maternal or paternal history of disease. However, our data did 
not support the hypothesis that among male offspring a mater-
nal history of disease would be associated with a greater magni-
tude of risk compared with a paternal history of disease. Rather, 
similar levels of risk were also seen among male offspring with 
maternal versus paternal disease history. Our results remained 
consistent in sensitivity analyses accounting for calendar time, 
and after the exclusion of families with more than one affected 
offspring case.
An overarching question in autoimmune disease research is 
which factors drive the strong female preponderance of disease. 
The idea that sex-chromosomal factors are involved is intrigu-
ing, and epidemiological research is needed in concert with 
basic science research in this area. Candidate X-chromosomal 
genes that may be associated with autoimmune diseases are 
beginning to be identifi ed. For example, at least two single 
nucleotide polymorphisms on the X chromosome (variants of 
TIMP1 and IL9R) have recently been associated with RA in 
genome-wide linkage and association studies.6 Sawalha et al26 
demonstrated an association between variants of an X chromo-
some gene (MECP2) and SLE in two independent populations. 
Interleukin-1 receptor-associated kinase 1 (IRAK1), another gene 
located on the X chromosome, may be a disease-susceptibility 
factor in human lupus, and animal models suggest that block-
ing IRAK1 can prevent murine lupus.7 As MECP2 and IRAK1 
are located in close proximity to each other (on Xq28), link-
age disequilibrium at this locus could underlie the apparent 
Table 2 Sensitivity analyses adjusted for birth year and excluding families with more than one offspring with disease
Parental history of 
disease
Female offspring Male offspring
Adjusted for birth year
Excluding families with more 
than one affected offspring Adjusted for birth year
Excluding families with more than one 
affected offspring
HR (95% CI)* p Value† HR (95% CI)* p Value† HR (95% CI)* p Value† HR (95% CI)* p Value†
Maternal SLE
 No Referent 0.9059 Referent 0.7710 Referent 0.9872 Referent 0.9754
 Yes 14.1 (8.7 to 22.80 12.7 (7.6 to 21.2) 5.6 (0.8 to 39.6) 5.6 (0.8 to 39.8)
Paternal SLE
 No Referent Referent Referent Referent
 Yes 15.0 (6.2 to 36.1) 14.8 (6.1 to 35.6) 0 (0)‡ 0 (0)‡
Maternal RA
 No Referent 0.7136 Referent 0.5984 Referent 0.4510 Referent 0.7208
 Yes 2.8 (2.4 to 3.2) 2.6 (2.2 to 3.0) 2.6 (2.1 to 3.2) 2.5 (2.0 to 3.1)
Paternal RA
 No Referent Referent Referent Referent
 Yes 2.9 (2.4 to 3.5) 2.7 (2.3 to 3.3) 3.0 (2.3 to 3.9) 2.6 (2.0 to 3.5)
Maternal RA/JRA
 No Referent 0.9909 Referent 0.7453 Referent 0.5683 Referent 0.7111
 Yes 2.9 (2.6 to 3.3) 2.5 (2.2 to 2.9) 2.6 (2.1 to 3.2) 2.3 (1.8 to 2.8)
Paternal RA/JRA
 No Referent Referent Referent Referent
 Yes 2.9 (2.4 to 3.5) 2.6 (2.2 to 3.2) 2.9 (2.2 to 3.7) 2.4 (1.8 to 3.2)
*Also adjusted for maternal/paternal history.
†p Value comparing maternal versus paternal history risk estimates.
‡Upper bound not calculated due to no cases among male offspring.
JRA, juvenile rheumatoid/idiopathic arthritis; SLE, systemic lupus erythematosus; RA, rheumatoid arthritis.
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separate genetic associations. Another line of investigation is 
the identifi cation of X-chromosomal genes with functional rel-
evance to autoimmune disease. For instance, abnormalities in 
apoptosis have been observed in autoimmune diseases such as 
SLE,27 and at least 17 X chromosome genes, including CD40LG, 
have apoptosis listed as a gene ontology term.28 However, our 
epidemiological fi ndings of similar magnitudes of risk, regard-
less of the sex of the affected parent, indicate that for both SLE 
and RA, genetic factors associated with the sex chromosomes 
do not play a major role in disease risk at the population level. 
Coupled with the observation that individual single nucleotide 
polymorphisms recognised as being associated with SLE and RA 
correspond to small magnitudes of risk (OR individually <2), our 
fi ndings may imply that epigenetic rather than genetic factors 
are relevant to the sex disparities observed in the risk of these 
autoimmune diseases.
Incomplete inactivation of the second X chromosome in 
women may be one epigenetic mechanism involved in autoim-
mune disease, by allowing the overexpression of X-chromosomal 
genes in women. Lu et al 29 provided evidence that demethy-
lation of regulatory sequences on the inactive X chromosome 
and associated overexpression may be a factor in autoimmune 
disease. They found that CD40LG (a B-cell co-stimulatory mol-
ecule, encoded on the X chromosome) is unmethylated in men, 
while women have both a methylated and an unmethylated 
copy. Moreover, they demonstrated in a series of experiments 
on T cells isolated from lupus patients that CD40LG is overex-
pressed on CD4 T cells in women, but not men, corresponding 
to demethylation of CD40LG in women. Research is ongoing to 
determine if similar fi ndings apply to other genes on the inactive 
X chromosome. A non-genomic concept that should be consid-
ered in the context of the parental origin of effects is the trans-
mission of non-inherited maternal antigens (NIMA), which can 
occur transplacentally or by breastfeeding.30 Exposure to NIMA 
may infl uence immune modelling,31 and NIMA have been asso-
ciated with both an increased32–34 and decreased35 risk of RA, 
whereas data do not support a role for NIMA in association with 
the risk of SLE.36
Our results contrast with those from a US-based registry 
study of SLE multiplex families, in which 22% of 68 SLE parents 
with SLE offspring were men. This led the authors to infer that 
men were overrepresented as parents of offspring with SLE.37 
However, because that study was composed of families with at 
least two SLE cases rather than being population based, it may 
have been subject to selection biases, such as the inclusion of 
cases with greater genetic risk or disease severity, or a greater 
tendency for men with affected offspring to participate due to 
the rarity of SLE in men.
A phenomenon termed the ‘Carter effect’, fi rst described for 
pyloric stenosis,38 predicts a greater magnitude of disease trans-
mission in the sex with the lower baseline predisposition for 
disease (men in the cases of SLE and RA), based on the theory 
that a greater genetic load would be necessary for disease pen-
etrance in the less affected sex. Support for the Carter effect 
was reported for multiple sclerosis, another autoimmune dis-
ease with a female preponderance,39 but was refuted in another 
study.40 While a higher genetic load has recently been reported 
for men compared with women with SLE,41 our results do not 
provide support for the Carter effect in either SLE or RA.
A number of study limitations should be noted. First, SLE and 
RA cases included in the analysis were classifi ed based on ICD 
codes, rather than the fulfi lment of formal American College of 
Rheumatology classifi cation criteria, and it is well known that 
registry data are not completely accurate. However, American 
College of Rheumatology criteria also have limitations, and have 
been shown to have sensitivity and specifi city of less than 90% in 
research populations other than the original test  population.42 43 
While there may have been some misclassifi cation of case status, 
such misclassifi cation would be expected to be non-differential, 
and would therefore be expected to attenuate the reported risk 
estimates.44 Due to the small number of male SLE patients (in 
particular among male offspring), there may have been insuf-
fi cient power to detect potential sex-dependent effects for this 
diagnosis. Another concern is that family linkages were based 
on administrative data, not permitting us to confi rm biological 
parental status. Also, we were unable to assess the contribution 
of environmental factors, which may also cluster in families, to 
disease expression.
A future direction will be to explore the possibility of genetic 
anticipation in the SLE and RA populations, which would be 
exhibited by a younger age of onset and increased disease sever-
ity among second generation cases. As a simple comparison of 
age of onset distributions from each generation is inappropri-
ate due to statistical considerations such as right truncation,45 
various methods have been developed for the study of genetic 
anticipation, including newer methods that incorporate data 
from unaffected family members.46–50 Another direction will 
be to investigate familial autoimmunity in broader terms, 
rather than focusing on the patterns of single diseases within 
families. Various combinations of autoimmune diseases have 
been shown to cluster within families and individuals,1 51 52 
and shared heritable pathogenic factors, such as dysregulation 
of the interferon-α system in several autoimmune conditions, 
have been suggested.53 54 While autoimmune diseases may have 
genetic and environmental risk factors in common, the interplay 
of such factors may infl uence the particular autoimmune pheno-
types that are expressed.55 56
In conclusion, our study shows a strong familial risk for SLE 
and a more moderate familial risk for RA. For both diseases, we 
found equivalent disease transmission among both female and 
male offspring of maternal compared with paternal cases. These 
results do not support the concept of the Carter effect in SLE 
or RA, and provide indirect evidence on a population level that 
X-chromosomal factors do not play a major role in sex dispari-
ties observed for the risk of SLE and RA.
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